Duncan D. McCulloch is the CEO of IDEXX Laboratories, a leader in veterinary diagnostics and software. With a background in Biomedical Engineering from the University of Toronto and an MBA from Harvard, McCulloch knows both the science and business sides...

Duncan D. McCulloch is the CEO of IDEXX Laboratories, a leader in veterinary diagnostics and software. With a background in Biomedical Engineering from the University of Toronto and an MBA from Harvard, McCulloch knows both the science and business sides of the company. He has led IDEXX since April 2022, transitioning the company into a new era of innovation. Under his management, IDEXX has aimed for strong financial performance, aligning the company’s goals with science-driven health solutions. Interestingly, McCulloch's compensation in 2022 totaled around $11.7 million, consisting of a $1 million salary and significant stock options, reflecting his belief in long term performance. What stands out is his insightful approach to strategic planning, which has been key in driving growth and shareholder value. Also notable is how he has navigated IDEXX through market fluctuations, ensuring growth even during challenging times, which has increased his personal wealth to over $24 million in organizational stock. Before his tenure at IDEXX, he gained valuable experience in the field, which he uses to drive the company's success today.